Rational Design and Synthesis of 4-((1R,2R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications

    October 2008 in “ Journal of medicinal chemistry
    Jie Jack Li, Donna M. Iula, Maria Nguyen, Lufei Hu, Danielle Dettling, Theodore R. Johnson, Daniel Du, Veerabahu Shanmugasundaram, Jennifer A. Van Camp, Zhi Wang, William G. Harter, Wen-Song Yue, Mark L. Boys, Kimberly Wade, Elena Drummond, Brian Samas, Bruce A. Lefker, Garrett Hoge, Michael Lovdahl, Jeffrey Asbill, Matthew Carroll, Mary Ann Meade, Susan Ciotti, Theresa Krieger-Burke
    TLDR PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.
    The document detailed the rational design and synthesis of PF-998425, a novel, nonsteroidal androgen receptor antagonist intended for dermatological use. The compound was specifically engineered to avoid phototoxicity, a common issue with similar treatments. The research involved multiple departments, including Chemistry, Dermatology Biology, Pharmaceutical Sciences, Pharmacokinetics and Drug Metabolism, and Drug Safety, all within Pfizer Global Research & Development. The study highlighted the collaborative effort across various specialized fields to develop a safer and effective treatment for conditions requiring androgen receptor antagonists.
    Discuss this study in the Community →

    Cited in this study

    8 / 8 results